7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,548.99

+307.67

+0.40%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqGM - Delayed Quote USD

Immutep Limited (IMMP)

3.0600 -0.2700 (-8.11%)

At close: October 30 at 4:00:00 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Immutep Quarterly Activities Report Q1 FY27

GlobeNewswire 2d ago

IMMP
-8.11%
Immutep Receives A$2.16 million French R&D Tax Incentive

GlobeNewswire 3d ago

IMMP
-8.11%
Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026

GlobeNewswire 8d ago

IMMP
-8.11%
Immutep Announces Late-Breaking Abstract on IMP761 Accepted for Poster Presentation at ACR Convergence 2026

GlobeNewswire 12d ago

IMMP
-8.11%
Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research

GlobeNewswire 17d ago

IMMP
-8.11%
Immutep Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire 18d ago

IMMP
-8.11%
Immutep Receives ~A$0.86 Million R&D Tax Incentive

GlobeNewswire 1mo ago

IMMP
-8.11%
Change to American Depositary Share Ratio

GlobeNewswire 1mo ago

IMMP
-8.11%
Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)

GlobeNewswire 1mo ago

IMMP
-8.11%
Immutep Quarterly Activities Report Q4 FY26

GlobeNewswire 3mo ago

IMM.AX

IMMP
-8.11%
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

GlobeNewswire 3mo ago

IMMP
-8.11%
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight

GlobeNewswire 3mo ago

JNJ

IMMP
-8.11%

Performance Overview

Return	IMMP	S&P/ASX 200 [XJO] (^AXJO)
YTD	+6.99%	+2.22%
1-Year	+59.38%	+0.29%
3-Year	+67.21%	+31.37%

Mobilize your Website

View Site in Mobile | Classic

Share by: